TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SOPH

SOPHiA GENETICS SA

Healthcare · Health Information Services

8.30$ +1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

SOPHiA GENETICS SA (SOPH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 198 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SOPH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
206 206 180 181 178 155 147 178 163 163 157 198
153 148 125 126 117 99 90 117 103 99 96 137
133 123 104 105 96 80 69 95 82 70 65 108
133 123 104 105 96 80 69 95 82 70 65 108
9.8 15 11 9.9 9.8 8.7 11 9.5 8.5 17 14 14
5.2 6.5 6.0 6.5 6.5 5.9 5.1 6.2 6.7 6.4 7.1 7.1
22 – – – – – – – – – – –
– 9.0 – – – 8.3 30 34 – 9.6 36 –
24 18 26 27 30 21 30 34 35 26 – 36
47 55 48 60 64 59 61 101 103 116 111 115
29 36 30 29 31 27 29 34 37 51 47 51
2.9 2.9 2.7 2.6 2.5 2.2 2.3 2.5 2.6 2.7 2.7 2.7
6.0 2.3 6.2 5.3 5.9 1.9 4.6 7.7 6.1 5.3 13 12
– – – 13 13 13 13 47 48 48 48 48
158 151 132 121 114 96 86 77 61 47 46 83
-354 -378 -391 -407 -425 -440 -458 -480 -500 -519 -539 -561
65 65 65 66 66 66 67 67 68 68 71 74

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?